“Farmak” has become the most expensive Ukrainian brand among drug manufacturers
[ad_1]
NV magazine and research company MPP Consulting compiled a list of the country’s most expensive brands. The “Farmak” company also entered the top-50 list, receiving the highest rating in the “Medicine and pharmaceuticals” segment.
The total expected value of the most expensive brands in Ukraine is $2.4 billion. The list includes retail and e-commerce companies, manufacturers of food products, alcoholic and non-alcoholic beverages, household goods, telecommunications, fuel, energy companies, etc.
Production facilities of the pharmaceutical company “Farmak” in Kyiv
As MPP Consulting specialists explain, brand value is exclusively the value of a trademark without taking into account production facilities, company infrastructure, patents, inventions, and other material or intellectual assets. The formula for calculating brand value is the product of four factors: investment, geographic, technological and competitive, as well as a unique identifier and a composite financial indicator.
For thirteen years in a row, “Farmak” is the leader of the pharmaceutical market of Ukraine in terms of sales of medicinal products in monetary terms*. Today, the products of the domestic manufacturer are represented in Ukraine and more than 50 countries of the world.
*according to Proxima Research
Information about the company
“Farmak” is the leader* of the pharmaceutical market of Ukraine. The company’s product portfolio includes more than 400 names of medicinal products. Every year “Farmak” brings about 20 new medicines to the market.
Farmak has representative offices in Uzbekistan, Kazakhstan, Kyrgyzstan and Vietnam, as well as international offices in Poland and the UAE. In 2023, marketing companies in the Czech Republic and Slovakia were acquired.
In 2024, it is planned to open a production facility in Spain, where complex generic drugs will be manufactured: anesthesia, antithrombotic drugs, systemic hormones, psycholeptics, drugs for diseases of the cardiovascular system, antipsychotic drugs, etc.
Farmak annually reinvests up to 90% of its profits in development. The production facilities, laboratory and technical complex of the enterprise have international certification and meet the high requirements of European GMP standards (approx. Good Manufacturing Practice).
The company’s products are exported to more than 50 countries. Among them are the countries of Central Asia, South America, Great Britain, Slovakia, Germany, Australia, Israel, Portugal and others.
*According to the volume of sales of medicinal products in monetary terms, according to data from Proxima Research, 2022.
[ad_2]
Original Source Link
